Related Experiment Video
Updated: Mar 8, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Movement-activated cortical myoclonus in Dravet syndrome
Laura Canafoglia1, Francesca Ragona2, Ferruccio Panzica1
1Neurophysiopathology and Epilepsy Centre, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Multifocal myoclonus, a consistent feature in Dravet syndrome (DS) patients with SCN1A mutations, originates from cortical motor areas. This condition differs from progressive myoclonus epilepsy and can cause disability.
Area of Science:
- Neuroscience
- Genetics
- Epilepsy Research
Background:
- Dravet syndrome (DS) is a severe form of epilepsy often associated with SCN1A gene mutations.
- Multifocal myoclonus has been observed in DS but not systematically characterized.
- Understanding the origin and features of myoclonus in DS is crucial for patient management.
Purpose of the Study:
- To systematically characterize multifocal myoclonus in patients with Dravet syndrome.
- To investigate the electrophysiological features and cortical origin of myoclonus in DS.
Main Methods:
- EEG-EMG recordings were analyzed in 19 patients with DS and SCN1A mutations.
- Myoclonus was evaluated using EMG activity in antagonist muscles and cortico-muscular coherence (CMC).
- Somatosensory evoked potentials (SSEPs) and long-loop reflexes (LLRs) were also assessed.
Main Results:
- All patients exhibited multifocal action myoclonus with synchronous EMG bursts in antagonist muscles, peaking in the beta band.
- Significant beta band CMC and short cortico-muscular transfer times indicated a cortical origin.
- Myoclonic seizures were associated with greater CMC; SSEPs and LLRs were not consistently enhanced.
Conclusions:
- Cortical myoclonus is a consistent feature of Dravet syndrome linked to SCN1A mutations.
- This myoclonus shares similarities with, but is distinct from, progressive myoclonus epilepsy.
- The findings suggest myoclonus is an intrinsic, potentially disabling feature of DS, possibly arising from cortical network dysfunction.
More Related Videos
07:35Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists